Deregulated Fcγ Receptor Expression in Patients With CIDP

Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000148
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Fcγ-Receptor 3B ( FCGR3B ) Copy Number Variations in Patients With Eosinophilic Granulomatosis With Polyangiitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Fcγ Receptor Targeting in RA

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Gene Expression Data Analysis Identifies Multiple Deregulated Pathways in Patients With Asthma

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Role of CrkII in Fcγ Receptor-Mediated Phagocytosis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Deregulated Aiolos Expression in Common Variable Immunodeficiency

The Open Immunology Journal
2009English

Proteomics Based Identification of Proteins With Deregulated Expression in B Cell Lymphomas

PLoS ONE
Multidisciplinary
2016English

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+T Cells of Patients With Relapsing-Remitting Multiple Sclerosis

Journal of Immunology Research
MedicineAllergyImmunology
2014English

Blocking HIV-1 Replication: Are Fc–Fcγ Receptor Interactions Required?

Journal of Clinical Investigation
Medicine
2018English

Differential Gene Expression of Activating Fcγ Receptor Classifies Active Tuberculosis Regardless of Human Immunodeficiency Virus Status or Ethnicity

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy